Dr. Raymond Liu, MD, discusses a new research paper that details how Kaiser Permanente Northern California (KPNC) quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic. The paper published in JCO Oncology Practice, titled “Telehealth in Oncology During the COVID19 Outbreak: Bringing the house call back virtually,” offers insights for medical centers and health systems throughout the country that are facing similar challenges.
Raymond Liu, M.D., is a medical oncologist at Kaiser Permanente San Francisco, and serves as the Director of Research at The Permanente Medical Group’s Hematology-Oncology service line, overseeing hematology and cancer research. Dr. Liu has a research interest in implementation science with special emphasis on cancer survivorship and the care journey. He has published numerous articles in peer-reviewed publications on a variety of oncology topics. Dr. Liu received his undergraduate degree from Harvard University and his medical degree from University of Chicago’s Pritzker School of Medicine. He completed his residency and fellowship at University of California, San Francisco. Dr. Liu is an Assistant Clinical Professor at the University of California, San Francisco.